Buys | $0 | 0 | – |
Sells | $0 | 0 | – |
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous pemphigoid. Akari Therapeutics, Plc is based in London, the United Kingdom.
Over the last 12 months, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of Akari Therapeutics, Plc stock.
On average, over the past 5 years, insiders at Akari Therapeutics, Plc have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,055,600 shares for transaction amount of $200,036 was made by Cohen Mark S (director) on 2015‑09‑18.
2015-09-18 | Cohen Mark S | director | 1.06M 0.0711% | $0.19 | $200,036 | -56.76% | ||
2014-04-15 | SABBY MANAGEMENT, LLC | 10 percent owner | 17,100 0.3007% | $5.00 | $85,500 | +9.59% | ||
2014-04-14 | SABBY MANAGEMENT, LLC | 10 percent owner | 3,000 0.0539% | $5.21 | $15,630 | +7.49% | ||
2014-04-11 | SABBY MANAGEMENT, LLC | 10 percent owner | 100 0.0017% | $5.15 | $515 | +3.71% | ||
2014-04-10 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,400 0.0252% | $5.25 | $7,350 | +6.67% | ||
2014-04-09 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,075 0.0194% | $5.51 | $5,923 | +1.82% | ||
2014-04-08 | SABBY MANAGEMENT, LLC | 10 percent owner | 35,500 0.6218% | $5.36 | $190,280 | +1.82% | ||
2014-04-07 | SABBY MANAGEMENT, LLC | 10 percent owner | 20,654 0.3716% | $5.71 | $117,840 | -1.75% | ||
2014-04-04 | SABBY MANAGEMENT, LLC | 10 percent owner | 12,250 0.216% | $6.07 | $74,400 | -9.44% | ||
2014-04-02 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,500 0.0441% | $6.15 | $15,375 | -10.49% | ||
2014-04-01 | SABBY MANAGEMENT, LLC | 10 percent owner | 15,371 0.2742% | $6.10 | $93,806 | -8.58% | ||
2014-03-31 | SABBY MANAGEMENT, LLC | 10 percent owner | 7,936 0.1396% | $6.35 | $50,394 | -13.25% | ||
2014-03-27 | SABBY MANAGEMENT, LLC | 10 percent owner | 1,700 0.0344% | $6.61 | $11,237 | -14.55% | ||
2014-03-26 | SABBY MANAGEMENT, LLC | 10 percent owner | 14,200 0.2876% | $6.66 | $94,619 | -15.17% | ||
2014-03-25 | SABBY MANAGEMENT, LLC | 10 percent owner | 303 0.0061% | $6.90 | $2,091 | -18.78% | ||
2014-03-24 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,400 0.0465% | $6.71 | $16,104 | -19.29% | ||
2014-03-21 | SABBY MANAGEMENT, LLC | 10 percent owner | 4,900 0.1002% | $6.83 | $33,467 | -16.30% | ||
2014-03-20 | SABBY MANAGEMENT, LLC | 10 percent owner | 3,800 0.0768% | $6.90 | $26,220 | -18.12% | ||
2014-03-17 | SABBY MANAGEMENT, LLC | 10 percent owner | 2,400 0.0479% | $6.65 | $15,960 | -16.14% |
Increased Positions | 6 | +54.55% | 174,724 | +96.36% |
Decreased Positions | 2 | -18.18% | 33,262 | -18.34% |
New Positions | 5 | New | 169,328 | New |
Sold Out Positions | <1 | Sold Out | 33,260 | Sold Out |
Total Postitions | 15 | +36.36% | 322,783 | +78.02% |
Palo Alto Investors Lp | $158.00 | 0% | 146,024 | +146,024 | New | 2024-12-31 |
Omnia Family Wealth, Llc | $95.00 | 0% | 87,628 | 0 | 0% | 2024-12-31 |
Cerity Partners Llc | $26.00 | 0% | 23,643 | 0 | 0% | 2024-12-31 |
Renaissance Technologies Llc | $25.00 | 0% | 23,465 | +5,396 | +29.86% | 2024-12-31 |
Cresset Asset Management, Llc | $20.00 | 0% | 18,408 | 0 | 0% | 2024-12-31 |
Catalina Capital Group, Llc | $14.00 | 0% | 13,105 | +13,105 | New | 2024-12-31 |
Accent Capital Management, Llc | $11.00 | 0% | 10,000 | +10,000 | New | 2024-12-31 |
Ubs Group Ag | $0 | 0% | 194 | +194 | New | 2024-12-31 |
Bank Of America Corp /De/ | $0 | 0% | 150 | 0 | 0% | 2024-12-31 |
Osaic Holdings, Inc. | $0 | 0% | 100 | 0 | 0% | 2024-12-31 |